Online Medical Shop

My Cart:

0 item(s) - SAR0.00
You have no items in your shopping cart.

0

More Views

McGraw-Hill's 2018/2019 Top 300 Pharmacy Drug Cards 4th Edition

ISBN: 9781260108842

Shipping Weight: 1.74 KG

Availability: In stock

Stock Qty: 1

SAR236.26

Quick Overview

Pages: 608,
Specialty: Pharmacy,
Publisher: McGraw-Hill,
Publication Year: 2018,
Cover: Book,
Dimensions: 135x185x84mm

A fast, fun, and effective way to learn essential information about the top 300 drugs Includes audio Q&A with detailed discussion for each drug at Top300DrugCards.com and 15 BONUS CARDS ON VACCINES! Everything you need to know about the top 300 drugs in one easy-to-carry resource. Each card includes: - Generic and common name - Class - Dosage Forms - Approved Dose and Indications - Off-Label Use - Contraindications - Adverse Reactions - Drug Interactions - Monitoring Parameters - Medication Safety Issues and Black Box Warnings - Strong focus on patient safety Great for NAPLEX(R) and course review! Send feedback to the editors: Jill M. Kolesar, PharmD, MS, BCPS, FCCP, Professor, College of Pharmacy, Director, Early Phase Clinical Trials Center, Co-Director, Molecular Tumor Board, Markey Cancer Center, University of Kentucky. Email: jill.kolesar@uky.edu Lee Vermeulen, BSPharm, MS, FCCP, FFIP, Chief, Academic Service Lines, UK HealthCare and Professor of Medicine and Pharmacy, University of Kentucky. Email: Lee.Vermeulen@uky.edu show more

Weight: 1.74 KG
OR

Details

Pages: 608,
Specialty: Pharmacy,
Publisher: McGraw-Hill,
Publication Year: 2018,
Cover: Book,
Dimensions: 135x185x84mm

A fast, fun, and effective way to learn essential information about the top 300 drugs Includes audio Q&A with detailed discussion for each drug at Top300DrugCards.com and 15 BONUS CARDS ON VACCINES! Everything you need to know about the top 300 drugs in one easy-to-carry resource. Each card includes: - Generic and common name - Class - Dosage Forms - Approved Dose and Indications - Off-Label Use - Contraindications - Adverse Reactions - Drug Interactions - Monitoring Parameters - Medication Safety Issues and Black Box Warnings - Strong focus on patient safety Great for NAPLEX(R) and course review! Send feedback to the editors: Jill M. Kolesar, PharmD, MS, BCPS, FCCP, Professor, College of Pharmacy, Director, Early Phase Clinical Trials Center, Co-Director, Molecular Tumor Board, Markey Cancer Center, University of Kentucky. Email: jill.kolesar@uky.edu Lee Vermeulen, BSPharm, MS, FCCP, FFIP, Chief, Academic Service Lines, UK HealthCare and Professor of Medicine and Pharmacy, University of Kentucky. Email: Lee.Vermeulen@uky.edu show more

Weight: 1.74 KG

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.